Hematopathology Faculty Emily F. Mason M.D., Ph.D. Hematopathology Fellowship Director; Assistant Professor of PMI *To apply, please submit application, 3 letters of recommendation, cover Kelley J. Mast, M.D. letter, and CV to: Hematopathology Associate Fellowship Director; Holly Spann, Administrative Assistant Assistant Professor of PMI Vanderbilt University School of Medicine Jonathan Douds, M.D. Department of Pathology, Microbiology Assistant Professor of PMI & Immunology David R. Head, M.D. Hematopathology Division Professor of PMI T3218 MCN Ridas Juskevicius, M.D. 1161 21st Avenue Assistant Professor of PMI Nashville, TN 37232 Claudio A. Mosse, M.D., Ph.D. [email protected] Associate Professor of PMI; Chief of Pathology and Lab Medicine, VA *Application and pertinent information Tennessee Valley Healthcare System can be found at: Adam C. Seegmiller, M.D., Ph.D. https://www.vumc.org/gme/13198 Professor of Pathology, Microbiology & Immunology (PMI); Vice Chair for Clinical Pathology; Vanderbilt Director of Laboratory Medicine and Hematopathology University Aaron C. Shaver, M.D., Ph.D. Associate Professor of PMI; Medical Center Director, Immunopathology Mary Ann Thompson Arildsen, M.D., Hematopathology Ph.D. Fellowship Associate Professor of PMI; Director, Hematology Hematopathology at (DMT). Through the hematologic malignancy DMT and in collaboration with clinical colleagues in con- project, the pathologist guides clinical decision- ferences and clinical-pathologic case analyses. Our Vanderbilt University Medical making and effective test utilization in diagnos- group provides service for the 670-bed Vanderbilt Center ing and treating hematologic University Hospital, the 216-bed Monroe Carell Jr. disorders. Children's Hospital, and the 282-bed VA Tennessee The Hematopathology We offer a one- or two- Valley Healthcare System, the site of the largest Division was started in year ACGME accredited fel- stem cell transplant program in the VA system. the early 1970's by Dr. lowship that emphasizes Vanderbilt Medical Center is part of the 330-acre Robert D. Collins. Our diagnostic hematopathology Vanderbilt University campus in a sophisticated, mission is to provide 1) in the first year and research diverse residential community about 1.5 miles state-of-the-art diagnostic in the second year, for inter- from downtown Nashville, with numerous shops services integrating mor- ested trainees. Space is available in laboratories and restaurants within easy walking dis- phologic, immunopheno- of independent investigators for both clinical/ tance. Nashville, the capital of Tennessee, is the typic, molecular, and cytogenetic studies, 2) translational, as well as basic research projects. site of numerous colleges and universities, two resident training in the basics of hemato- The immunopathology and molecular genetics medical schools, and several large teaching hospi- pathology, 3) fellowship training that empha- laboratories are an integral part of the division tals. The city has an extensive parks system, a sizes the development of academic hemato- and provide opportunities for training and re- symphony orchestra, opera, ballet, performing arts pathologists, and 4) research opportunities search for both residents and fellows. center, zoo, several museums, The Country Music with hematopathology faculty. Current areas The division evaluates ~5,400 Hematopathol- Hall of Fame and the Grand Ole Opry. The city of- of investigation include the molecular basis of ogy cases including ~3,000 in-house bone mar- fers a wide variety of cultural, educational, and rec- leukemogenesis and lymphomagenesis, appli- rows, 550 in-house tissue biopsies, 1,000 body reational opportunities, including a professional cation of molecular and flow cytometric tech- fluids, and 1,100 consults/referrals, as well as football team and hockey team. The Nashville Met- nology to the diagnosis of hematolymphoid over 6,000 flow cytometry cases per year from ropolitan area is home to ~1.2 million inhabitants. neoplasms, and the pathogenesis of myelo- Vanderbilt Hospitals and an additional 900 mor- dysplasia. phology cases and nearly 1,000 flow cytometry Vanderbilt is at the cutting edge of incorpo- cases per year from the VA Tennessee Valley rating advanced diagnostics into patient care. Healthcare System. Data from flow cytometry, Through innovative technological interfaces immunohistochemistry and molecular genetics with the electronic medical record, the studies including next generation sequencing are hematopathologist can quickly review a pa- integrated into a single final diagnosis. Residents tient’s history and previous lab results to di- and fellows participate actively with the faculty rect the entire panel of lab tests that need to be ordered for every patient receiving a bone State of the Art Minimal Residual Disease Testing marrow biopsy. Once the results from the cy- togenetic, molecular and flow cytometry re- ports are available, they are incorporated into an over-arching comprehensive report that includes not only diagnostic information but Pathology, Microbiology & Immunology also specifies prognosis and optimal methods Division of Hematopathology for minimal residual disease detection. This T3218 MCN suite of services integrating the ordering and 1161 21st Avenue Nashville, TN 37232 interpretation of morphologic and laboratory data is the Diagnostic Management Team (615) 322-0146 [email protected] .